Scientists have discovered a strategy from colon cancer tumor cells to induce chemotherapy.

Published Date: 02 Mar 2023

Platinum-based chemotherapy used to treat advanced cancer can preserve healthy cells around cancer cells and thus reduce the tumor's susceptibility to treatment. This shows that...

Read Full News

Latest News

Education Gap Tied to Higher Risk for Young-Onset CRC Death

Researchers analyze trends in colorectal cancer mortality among adults aged 25-49 years in a study spanning about three decades.

Aspirin Unlikely to Cut Colorectal Cancer Incidence

A Cochrane Review finds aspirin likely results in little to no difference in colorectal cancer incidence at a follow-up of 5 years to less than 15 years.

Tumor Genomic Testing: Too Little, Too Late

Tumor genomic testing is critical to informed treatment decisions, but researchers find that it’s used in too few patients and often too late.

High-Impact Exercise Linked to Anal Incontinence in Women

High-impact sports may increase the risk for anal incontinence, especially among women, with many cases underdiagnosed because of stigma and low awareness.

Spyre's Inflammatory Bowel Drug Shown to Reduce Disease Activity in Mid-stage Study

Spyre Therapeutics said on Monday its experimental drug showed a significant reduction in disease activity when ⁠tested in patients with ulcerative colitis in a mid-stage...

Age and Visceral Fat May Trend Together: What to Know

Why fat that surrounds organs is more dangerous continues to be studied.

Todays Updates

Is Vitamin D a Key to Better Breast Cancer Survival?

A prospective study links sufficient vitamin D levels at the time of breast cancer diagnosis to improved overall survival.

Todays Updates

Is Vitamin D a Key to Better Breast Cancer Survival?

A prospective study links sufficient vitamin D levels at the time of breast cancer diagnosis to improved overall survival.

Latest News

Researchers analyze trends in colorectal cancer mortality among adults aged 25-49 years in a study spanning about three decades.

A Cochrane Review finds aspirin likely results in little to no difference in colorectal cancer incidence at a follow-up of 5 years to less than 15 years.

Tumor genomic testing is critical to informed treatment decisions, but researchers find that it’s used in too few patients and often too late.

High-impact sports may increase the risk for anal incontinence, especially among women, with many cases underdiagnosed because of stigma and low awareness.

Spyre Therapeutics said on Monday its experimental drug showed a significant reduction in disease activity when ⁠tested in patients with ulcerative colitis in a mid-stage...

Why fat that surrounds organs is more dangerous continues to be studied.

News All Time

New GERD Score May Help Clinicians Spot Biggest Symptom

In patients with GERD, dominant symptom intensity is a simple patient-reported measure that identifies the most burdensome symptom and tracks treatment response.

Can a Machine Learning Model Predict Liver Cancer?

Using routine clinical data, the model gauges liver cancer risk better than existing tools, offering a potential way to identify high-risk patients missed by current screening criteria.

IUS May Guide Treatment in Children With Ulcerative Colitis

Intestinal ultrasound scan may serve as an early non-invasive predictor of corticosteroid resistance and short-term colectomy in children with acute severe ulcerative colitis.

Routine EHR Data May Help Predict Pancreatic Cancer Risk

A risk model that uses routine clinical data can identify people at high risk of developing pancreatic cancer over the next 3 years.

Can Romiplostim Reduce Chemo Disruptions in GI Cancer?

A recent analysis assesses whether romiplostim can reduce thrombocytopenia-driven chemotherapy dose reductions, delays, and discontinuations.

Tumor Debulking Fails to Boost Survival in Metastatic CRC

Researchers evaluated whether adding tumor debulking to standard palliative systemic therapy improves survival in patients with multiorgan metastatic colorectal cancer in the ORCHESTRA trial.

Analysis-Pediatricians Win Round 1 in Vaccine Fight, but Damage Has Been Done

A federal court injunction on Monday put a check on Health Secretary Robert F. Kennedy Jr.'s rapid assault on U.S. vaccine recommendations, but months of turmoil and...

Tx Delays in CRC More Common in Urban Men, Racial Minorities

A study using data from Surveillance, Epidemiology, and End Results evaluates how sex, race, and geographic disparities affect treatment timeliness in patients with early-onset colorectal cancer.

‘Failure to Thrive’ Now ‘Faltering Weight’ in Pediatrics

The World Health Organization also recommends using a z-score for diagnosing faltering weight, in addition to growth charts.

From Royal Courts to Clinics: How Enemas Evolved

Once considered a universal remedy, enemas are now used selectively for specific clinical indications, such as bowel preparation.

Popular Caraway Oil for Dyspepsia: Benefit or Risk?

Caraway oil is widely used for digestive symptoms; however, strong clinical evidence supports its use in combination with peppermint oil for functional dyspepsia.

Duchenne Gene Therapy Shows Improved Muscle Function in Trial

Regenxbio said on Wednesday that interim data from a early-to-mid stage study of its experimental gene therapy ⁠in patients with Duchenne muscular dystrophy showed continued...

Early Top-Down Therapy Cuts Surgery Risk in Crohn’s

Five-year PROFILE follow-up shows early top-down infliximab-based therapy markedly reduces abdominal surgery and hospitalizations in Crohn’s vs step-up escalation.

Commercial Microbiome Tests: Unreliable Results

Study finds major methodological differences across seven direct-to-consumer stool tests, producing taxonomic profiles as variable as those between individuals — limiting clinical use.

Neoadjuvant GOLP Boosts Event-Free Survival in Liver Cancer

A phase 2/3 trial evaluates the efficacy and safety of neoadjuvant therapy with gemcitabine-oxaliplatin, lenvatinib, and toripalimab in patients with high-risk intrahepatic cholangiocarcinoma.

AI Beats Conventional Endoscopy in Neoplasm Detection

AI-assisted esophagogastroduodenoscopy is more effective than the conventional procedure in detecting upper GI neoplasms, particularly for lesions measuring ≤ 10 mm.

Recommended News For You

Medical debt in collections persists after cancer diagnosis

Non-Hodgkin lymphomas that are indolent have been linked to psychological distress.

A researcher has found that yoga exhibits the "most improvement" in helping long-term cancer survivors restore their brain health.

In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.

LAIs vs Oral Antipsychotics for Bipolar I Rehospitalization

Herpes virus-based vaccine shows promise in targeting tumors without side effects

Chemotherapy Boosts Survival for Older Patients With TNBC

Recommended Articles For You

CENP-H in Cancer: A Key Player in Tumor Progression and a Potential Therapeutic Target 

Cutting-Edge Cancer Care: The Precision Revolution in Surgical Oncology 

Exploring the Latest Advances in PTLD Cancer Treatment 

Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Teenagers Frequently Use Delta-8 THC; New Drug-Coated Balloon Treats Blocked Stents.

2.

Immunotherapy after surgery is good for patients with advanced cancer

3.

AI-based liquid biopsy shows promise for detecting brain cancer

4.

Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza'

5.

New BCMA-Directed Therapies Show Promise in Multiple Myeloma

1.

Surprising Symptoms of Prostate Cancer: What You Need to Know

2.

Oncological Surgery Today: Personalized, Interdisciplinary Approaches to Cancer Care

3.

Bridging the Global Divide: Enhancing Psychosocial Care for Cancer Survivors Across Income Settings

4.

Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts

5.

Unlocking the Potential of Reticulocytes: The Key to Enhanced Blood Production

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part XI

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC

4.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V

5.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot